Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Cygnus Capital Advisors, LLC | 329.3K | -- | 0.59% | -20.7K | 2026-06-30 |
| XTX Topco Ltd | 221.8K | -- | 0.40% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 138.4K | -- | 0.25% | +20.6K | 2026-06-30 |
| Citadel Advisors LLC | 56.1K | -- | 0.10% | -621.4K | 2026-06-30 |
| Vanguard Capital Management LLC | 50.4K | -- | 0.09% | -- | 2026-06-30 |
| Goldman Sachs Group Inc | 40.2K | -- | 0.07% | -- | 2026-06-30 |
| StoneX Group Inc. | 26.1K | -- | 0.05% | -- | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 23.0K | -- | 0.04% | -- | 2026-06-30 |
| State Street Corp | 19.0K | -- | 0.03% | -- | 2026-06-30 |
| UBS Group AG | 16.7K | -- | 0.03% | -37.8K | 2026-06-30 |
